semaglutide approved by fda US approves weight loss drug Wegovy to prevent cardiovascular events FDA Approves Oral Semaglutide: First

Duah notes that rapid weight loss can accelerate bone loss, and without enough vitamin D and calcium, the risk of osteoporosis may increase over time

For example, in Q3 2025 Loreally, Wegovy and Eli Lillys GLP-1 drugs together drove $10.0 billion or about 52% of Lillys quarterly revenue ( [30] )

Protein can help maintain muscle mass during fat loss and fiber can help reduce constipation, a potential GLP-1 medication side effect

Scapagnini, Funct

How to use: Take one tablet daily preferably empty stomach

Macrodosing pushes the medication to a level where appetite suppression, slowed gastric emptying, and insulin signaling are not just supportive, but central drivers of measurable change